All articles tagged with #lymphoma
Bret Hanna-Shuford, a Broadway actor and social media influencer known for his role in productions like Wicked and for documenting his life as a gay parent with his husband Stephen, has died at 46 after battling lymphoma and HLH. He was also working on a children's book and is survived by his family, including his son Maverick.
Dave Coulier, known for 'Full House,' announced he has Stage 3 tongue cancer, diagnosed after a routine PET scan, following his previous battle with lymphoma. He is undergoing 35 rounds of radiation and is optimistic about his prognosis, emphasizing the importance of early detection and healthy products.
Jessica Farrington shared her experience of ignoring early signs of non-Hodgkin follicular lymphoma, emphasizing the importance of listening to one's body and seeking medical attention for subtle symptoms to enable early diagnosis and treatment.
A pregnant woman in England experienced severe symptoms mistaken for morning sickness, but was later diagnosed with a fast-growing lymphoma, leading her to make the difficult decision to terminate her pregnancy to begin life-saving treatment. She has since gone into remission and is raising funds for lymphoma awareness.
Johnson & Johnson's early-stage clinical trial of a dual-targeting CAR-T therapy for lymphoma shows promising results, with a 100% response rate in patients with prior treatment, and manageable safety profile, marking a significant step forward in blood cancer treatment.
Jessica DeCristofaro shares her journey of being misdiagnosed multiple times before discovering she had stage 4B Hodgkin's lymphoma. Initially dismissed as allergies or acid reflux, her persistent symptoms led to a critical diagnosis after visiting numerous doctors. Following intense chemotherapy and radiation, she went into remission and now supports other cancer patients through her blog and care packages. Her story highlights the importance of self-advocacy in healthcare.
NIH researchers have developed a five-drug combination therapy, ViPOR, that achieves lasting remissions in patients with aggressive B-cell lymphoma resistant to standard treatments. In a clinical trial, ViPOR led to complete tumor disappearance in 38% of patients and showed significant survival benefits, particularly in specific subtypes of diffuse large B-cell lymphoma (DLBCL). The treatment's side effects were generally mild to moderate, and further studies are planned to confirm its efficacy and explore its use in other lymphoma types.
A study by Lund University in Sweden found that people with tattoos have a 21% higher risk of developing lymphoma, a rare cancer affecting white blood cells. The research, which included 5,591 participants, suggests that the risk is influenced by the duration of time since getting the tattoo rather than its size. While the findings highlight potential health risks associated with tattoos, more research is needed to provide definitive recommendations.
A study by Lund University in Sweden found that having tattoos is associated with a 21% increased risk of lymphoma, a type of blood cancer. The research, published in eClinical Medicine, analyzed data from the Swedish National Cancer Register and adjusted for various lifestyle factors. While the study highlights a potential health risk, experts emphasize the need for further research to fully understand the link between tattoos and cancer.
A new study from Lund University in Sweden reveals that individuals with tattoos may have a 21% higher risk of developing lymphoma, regardless of the tattoo's size. The study, which involved nearly 12,000 participants, found that the risk is highest among those who got their first tattoo less than two years prior. Researchers call for more studies to understand the long-term health implications of tattoos as their popularity continues to rise.
A Swedish study suggests a potential link between tattoos and malignant lymphoma, but experts argue the findings are overstated and call for more research. The study found a 21% higher risk of lymphoma among tattooed individuals, but this association is not statistically significant. Experts emphasize that the main risk factors for lymphoma are not related to tattooing, and the study's conclusions should be interpreted with caution.
A Swedish study suggests a potential link between tattoos and malignant lymphoma, but experts argue the findings are overstated and more research is needed. The study found a 21% higher risk of lymphoma among those with tattoos, but this association is not statistically significant. Experts emphasize that the main risk factors for lymphoma are not related to tattooing, and the study's conclusions should be interpreted with caution.
A study by Lund University involving over 11,000 participants found that individuals with tattoos have a 21% higher risk of developing lymphoma. The research suggests that tattoos may trigger low-grade inflammation, potentially leading to cancer. Further studies are planned to explore the link between tattoos and other cancers and inflammatory diseases.
New research from Lund University in Sweden suggests that tattoos may increase the risk of lymphoma by 21%, prompting scientists to call for more studies on the long-term health impacts of tattoo ink. The study found that the immune system's response to tattoo ink, which is transported to the lymph nodes, could be a factor, although the exact mechanisms remain unclear.
A Swedish study published in E-Clinical Medicine suggests a potential link between tattoos and an increased risk of malignant lymphoma. Researchers from Lund University found that tattoo ink, which often contains carcinogenic chemicals, can trigger a low-grade inflammation and immune response, potentially leading to cancer. The study, which analyzed cases of malignant lymphoma diagnosed between 2007 and 2017, calls for more research to establish causality and explore the long-term health effects of tattoos.